Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Stem cells can convert to liver tissue, help restore damaged organ

02.06.2004


Bone marrow stem cells, when exposed to damaged liver tissue, can quickly convert into healthy liver cells and help repair the damaged organ, according to new research from the Johns Hopkins Kimmel Cancer Center.



In mouse-tissue cultures, scientists found that stem cells, in the presence of cells from damaged liver tissue, developed into liver cells in as little as seven hours. They also observed that stem cells transplanted into mice with liver injuries helped restore liver function within two to seven days. The work was published in the June 1 issue of the journal Nature Cell Biology.

Bone marrow stem cells, also known as hematopoietic stem cells, have the ability to differentiate and develop into all other blood and marrow cells. There has been debate among the scientific community over whether these cells also can differentiate into other tissue types such as the liver, says Saul J. Sharkis, Ph.D., senior author of the study and a professor of oncology at the Johns Hopkins Kimmel Cancer Center. Some studies suggest that the bone marrow cells fuse with other types of cells, taking on those cells’ properties. But in this study, the researchers found, through highly thorough analysis with a microscope and other tests, that the cells did not fuse, suggesting that "microenvironmental" cues from existing liver cells caused them to convert.


"The hematopoietic stem cells were capable of taking on many characteristics of liver cell types, including specific gene and/or protein expression as well as typical function," Sharkis says. "These events occurred rapidly after injury exposure and restored liver abnormalities, indicating that the cells converted."

This type of stem cell technique could eventually be used to treat chronic diseases such as diabetes, cirrhosis of the liver, heart disease and cancer, he says. He cautions that many more studies must be completed before the stem cell therapy can be tested in humans.

For the study, Sharkis and colleagues cultured bone marrow stem cells together with either normal or damaged liver tissue in tissue culture dishes. Liver tissue was taken from mice that had been exposed to liver-damaging drugs. The two cell types were separated by a thin, permeable wall. Researchers performed several tests looking for expression of liver proteins.

In as little as seven or eight hours after culture with the injured liver tissue, some of the stem cells expressed the typical proteins present in liver cells cytokeratin 18 or albumin. Two days after culture, nearly 3 percent of all stem cells expressed these proteins. The researchers also observed the expression of many other proteins and products normally manufactured by liver cells in their earliest stages -- all detected within eight to 48 hours of culture.

The team then used a sensitive microscope test to examine the sex chromosomes of the cells, as the stem cells were taken from male mice and the liver tissue was taken from female mice. They identified some stem cells of male donor origin with four sex chromosomes typical of liver cells but not stem cells, indicating that the stem cells themselves physically had started to change and did not fuse with the liver cells.

Finally, the team transplanted the stem cells into injured livers in female mice and studied the amount of conversion at two and seven days following the transplant. More converted cells were observed at seven days versus two days, suggesting that the cells remained viable and continued dividing or converting. The liver functions of mice receiving the stem cells recovered as early as two days after transplant.

Sharkis’ continuing studies will try to identify the environmental cues responsible for cells’ conversion, and examine the ability of stem cells to repair other organs.

The study was funded by the National Heart, Lung and Blood Institute, the Ludwig Foundation and Hopkins’ Institute for Cellular Engineering. Co-authors were Yoon-Young Jang M.D., Ph.D.; Michael I. Collector; Stephen B. Baylin, M.D.; and Anna Mae Diehl, M.D.


Jang, Yoon-Young et al, "Hematopoietic Stem Cells Convert Into Liver Cells Within Days Without Fusion," Nature Cell Biology, June 1, 2004.

Vanessa Wasta | EurekAlert!
Further information:
http://www.hopkinsmedicine.org/
http://www.hopkinskimmelcancercenter.org/

More articles from Health and Medicine:

nachricht The end of pneumonia? New vaccine offers hope
23.10.2017 | University at Buffalo

nachricht Scientists track ovarian cancers to site of origin: Fallopian tubes
23.10.2017 | Johns Hopkins Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Salmonella as a tumour medication

HZI researchers developed a bacterial strain that can be used in cancer therapy

Salmonellae are dangerous pathogens that enter the body via contaminated food and can cause severe infections. But these bacteria are also known to target...

Im Focus: Neutron star merger directly observed for the first time

University of Maryland researchers contribute to historic detection of gravitational waves and light created by event

On August 17, 2017, at 12:41:04 UTC, scientists made the first direct observation of a merger between two neutron stars--the dense, collapsed cores that remain...

Im Focus: Breaking: the first light from two neutron stars merging

Seven new papers describe the first-ever detection of light from a gravitational wave source. The event, caused by two neutron stars colliding and merging together, was dubbed GW170817 because it sent ripples through space-time that reached Earth on 2017 August 17. Around the world, hundreds of excited astronomers mobilized quickly and were able to observe the event using numerous telescopes, providing a wealth of new data.

Previous detections of gravitational waves have all involved the merger of two black holes, a feat that won the 2017 Nobel Prize in Physics earlier this month....

Im Focus: Smart sensors for efficient processes

Material defects in end products can quickly result in failures in many areas of industry, and have a massive impact on the safe use of their products. This is why, in the field of quality assurance, intelligent, nondestructive sensor systems play a key role. They allow testing components and parts in a rapid and cost-efficient manner without destroying the actual product or changing its surface. Experts from the Fraunhofer IZFP in Saarbrücken will be presenting two exhibits at the Blechexpo in Stuttgart from 7–10 November 2017 that allow fast, reliable, and automated characterization of materials and detection of defects (Hall 5, Booth 5306).

When quality testing uses time-consuming destructive test methods, it can result in enormous costs due to damaging or destroying the products. And given that...

Im Focus: Cold molecules on collision course

Using a new cooling technique MPQ scientists succeed at observing collisions in a dense beam of cold and slow dipolar molecules.

How do chemical reactions proceed at extremely low temperatures? The answer requires the investigation of molecular samples that are cold, dense, and slow at...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

3rd Symposium on Driving Simulation

23.10.2017 | Event News

ASEAN Member States discuss the future role of renewable energy

17.10.2017 | Event News

World Health Summit 2017: International experts set the course for the future of Global Health

10.10.2017 | Event News

 
Latest News

Microfluidics probe 'cholesterol' of the oil industry

23.10.2017 | Life Sciences

Gamma rays will reach beyond the limits of light

23.10.2017 | Physics and Astronomy

The end of pneumonia? New vaccine offers hope

23.10.2017 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>